UBS Group
NFYS.WS

UBS Group’s Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 NFYS.WS Stock Holding History

UBS Group’s Portfolio NFYS.WS Stock Details NFYS.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-341
Closed -$12 – 10452
2024
Q2 		$12 Buy
341
+250
+275% +$11 ﹤0.01% 9343
2024
Q1 		$5 Buy
+91
New +$4 ﹤0.01% 9147
2023
Q4 		– Sell
-1,200
Closed -$84 – 10187
2023
Q3 		$84 Buy
+1,200
New +$73 ﹤0.01% 8928
2023
Q1 		– Sell
-398
Closed -$28 – 10763
2022
Q4 		$28 Sell
398
-702
-64% -$63 ﹤0.01% 10534
2022
Q3 		$0 Hold
1,100
– – ﹤0.01% 11166
2022
Q2 		$0 Hold
1,100
– – ﹤0.01% 11174
2022
Q1 		$0 Hold
1,100
– – ﹤0.01% 11112
2021
Q4 		$1K Buy
+1,100
New +$571 ﹤0.01% 10065

Other funds holding NFYS.WS

CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
EAM
Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group's NFYS.WS Position: Q3 2024 in Review

UBS Group sold out of Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (NFYS.WS) in Q3 2024, closing a stake of 341 shares — an estimated $12 sold.

UBS Group first reported a position in NFYS.WS in Q4 2021 and held it in 8 quarters. The position peaked at $1K in Q4 2021. 5 funds tracked by Wall St. Rank hold NFYS.WS as of Q3 2024.

  • UBS Group reported no remaining Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2024 after selling out during the quarter.
  • UBS Group sold 341 Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2024, an estimated $12.
  • UBS Group first reported a position in Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2021 and held it in 8 quarters.
  • UBS Group's Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $1K in Q4 2021.
  • 5 funds tracked by Wall St. Rank held Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2024.

Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.